Disease Activity and Safety during Long-Term (104-Week) Treatment with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension

BLANCO GARCIA, FRANCISCO JAVIER

Estatísticas

Estatísticas

Ver Estatísticas de uso

Identificadores

Identificadores

URI: http://hdl.handle.net/20.500.11940/1077

ISSN: 2326-5191

Rexistro completo

Servizos

Servizos

RIS

Mendeley

Linksolver

Data de publicación

2015

Título da revista

Arthritis and Rheumatology

Tipo de contido

Publicación de congreso